CMED and Brazilian Tax Reform: consultation period opened for contributions to the list of medicines subject to a zero rate
In brief On Friday, July 3, the Brazilian Drug Market Regulation Chamber (“CMED”) held a meeting with the regulated sector to present the progress made and the outlook for the implementation of Supplementary Law No. 214/2025 (“LC No. 214/2025”), with emphasis on the opening of a period for contributions to the preparation of the preliminary […]
More than lawyers
More than an Office
Global network
